Critical transitions in a game theoretic model of tumour metabolism
暂无分享,去创建一个
[1] B. Van Houten,et al. Metabolic symbiosis in cancer: Refocusing the Warburg lens , 2013, Molecular carcinogenesis.
[2] M. Dewhirst,et al. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation. , 2010, Future oncology.
[3] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[4] Aram Galstyan,et al. Dynamics of Boltzmann Q learning in two-player two-action games. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.
[5] J. Koutcher,et al. Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment. , 2012, Experimental cell research.
[6] John D Nagy,et al. The ecology and evolutionary biology of cancer: a review of mathematical models of necrosis and tumor cell diversity. , 2005, Mathematical biosciences and engineering : MBE.
[7] Kati Räsänen,et al. Activation of fibroblasts in cancer stroma. , 2010, Experimental cell research.
[8] S. Weinhouse. On respiratory impairment in cancer cells. , 1956, Science.
[9] Franz Wind,et al. Über den Stoffwechsel von Tumoren im Körper , 1926, Klinische Wochenschrift.
[10] Jason W Locasale,et al. Metabolic flux and the regulation of mammalian cell growth. , 2011, Cell metabolism.
[11] T. Halazonetis,et al. Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.
[12] Chi V Dang,et al. Links between metabolism and cancer. , 2012, Genes & development.
[13] O. Feron,et al. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] Jan-Ulrich Kreft,et al. Use of Game-Theoretical Methods in Biochemistry and Biophysics , 2008, Journal of biological physics.
[15] C. Maley,et al. Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .
[16] S. Carpenter,et al. Catastrophic shifts in ecosystems , 2001, Nature.
[17] R. Moreno-Sánchez,et al. Energy metabolism transition in multi‐cellular human tumor spheroids , 2008, Journal of cellular physiology.
[18] A. Tsirigos,et al. Transcriptional evidence for the "Reverse Warburg Effect" in human breast cancer tumor stroma and metastasis: Similarities with oxidative stress, inflammation, Alzheimer's disease, and "Neuron-Glia Metabolic Coupling" , 2010, Aging.
[19] Franziska Hirschhaeuser,et al. Lactate: a metabolic key player in cancer. , 2011, Cancer research.
[20] S. Schuster,et al. Game-theoretical approaches to studying the evolution of biochemical systems. , 2005, Trends in biochemical sciences.
[21] F. Sotgia,et al. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment , 2013, Cell cycle.
[22] R. Deberardinis,et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis , 2007, Proceedings of the National Academy of Sciences.
[23] Chenguang Wang,et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution , 2010, Cell cycle.
[24] P. Fortina,et al. The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.
[25] David Basanta,et al. Exploiting ecological principles to better understand cancer progression and treatment , 2013, Interface Focus.
[26] S. Bonhoeffer,et al. Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.
[27] J. Alsner,et al. An evolutionary-game model of tumour-cell interactions: possible relevance to gene therapy. , 2001, European journal of cancer.
[28] A. Tsirigos,et al. Ketones and lactate “fuel” tumor growth and metastasis , 2010, Cell cycle.
[29] Han Xie,et al. Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. , 2014, Cell metabolism.
[30] F. C. Santos,et al. Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells , 2009, British Journal of Cancer.
[31] Julien Verrax,et al. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.
[32] Adrian L Harris,et al. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. , 2006, Cancer research.
[33] J. Crutchfield,et al. Coupled replicator equations for the dynamics of learning in multiagent systems. , 2002, Physical review. E, Statistical, nonlinear, and soft matter physics.
[34] M. Archetti. Evolutionary dynamics of the Warburg effect: glycolysis as a collective action problem among cancer cells. , 2014, Journal of theoretical biology.
[35] J. Hofbauer,et al. Evolutionary game dynamics , 2011 .
[36] S. Mendrinos,et al. The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer , 2012, Cancer biology & therapy.
[37] A. Deutsch,et al. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion , 2008, Cell proliferation.
[38] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[39] F. Sotgia,et al. Oncogenes induce the cancer-associated fibroblast phenotype: Metabolic symbiosis and “fibroblast addiction” are new therapeutic targets for drug discovery , 2013, Cell cycle.
[40] J. Freyer,et al. Regulation of growth saturation and development of necrosis in EMT6/Ro multicellular spheroids by the glucose and oxygen supply. , 1986, Cancer research.
[41] Robert Axelrod,et al. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. , 2008, Translational oncology.
[42] Kyle Summers,et al. Evolutionary biology of cancer. , 2005, Trends in ecology & evolution.
[43] Matthew G. Vander Heiden,et al. Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.
[44] M. Wall. Quantitative biology : from molecular to cellular systems , 2012 .
[45] R. Rossignol,et al. Choosing between glycolysis and oxidative phosphorylation: a tumor's dilemma? , 2011, Biochimica et biophysica acta.
[46] G. Semenza,et al. Uterine DCs are essential for pregnancy. , 2008, The Journal of clinical investigation.
[47] E. Bertini,et al. G.O.2 Mutations in LMOD3 cause severe nemaline myopathy by disrupting thin filament organisation in skeletal muscle , 2014, Neuromuscular Disorders.
[48] A. Levine,et al. The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.
[49] O. Feron,et al. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments , 2011, Disease Models & Mechanisms.
[50] Adam Ertel,et al. Evidence for a stromal-epithelial “lactate shuttle” in human tumors , 2011, Cell cycle.